These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 874815

  • 1. Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs.
    Blair ML, Reid IA, Ganong WF.
    J Pharmacol Exp Ther; 1977 Jul; 202(1):209-15. PubMed ID: 874815
    [Abstract] [Full Text] [Related]

  • 2. Role of peripheral adrenoreceptors and vasopressin in the suppression of plasma renin activity by L-dopa in carbidopa-treated dogs.
    Blair ML, Reid IA, Keil LC, Ganong WF.
    J Pharmacol Exp Ther; 1979 Sep; 210(3):368-72. PubMed ID: 480187
    [Abstract] [Full Text] [Related]

  • 3. Age-dependent depressor effect of L-dopa in dogs with inhibition of extracerebral dopa decarboxylase.
    Wilke WL.
    Pediatr Res; 1983 Nov; 17(11):924-5. PubMed ID: 6359046
    [Abstract] [Full Text] [Related]

  • 4. Role of central and peripheral mechanisms in the action of alpha-methyldopa on blood pressure and renin secretion.
    Frankel RJ, Reid IA, Ganong WF.
    J Pharmacol Exp Ther; 1977 May; 201(2):400-5. PubMed ID: 323462
    [Abstract] [Full Text] [Related]

  • 5. An effect of extrarenal beta adrenergic stimulation on the release of renin.
    Reid IA, Schrier RW, Earley LE.
    J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
    [Abstract] [Full Text] [Related]

  • 6. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM, Parks LC, Kopin IJ.
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of the renin-angiotensin-aldosterone system by L-dopa with and without inhibition of extracerebral dopa decarboxylase in man.
    Barbieri C, Caldara R, Ferrari C, Crossignani RM, Recchia M.
    Clin Sci (Lond); 1981 Aug; 61(2):187-90. PubMed ID: 7021041
    [Abstract] [Full Text] [Related]

  • 8. Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
    Antonaccio MJ, Kerwin L.
    J Pharmacol Exp Ther; 1976 Feb; 196(2):380-8. PubMed ID: 1255483
    [Abstract] [Full Text] [Related]

  • 9. Effect of L-DOPA on blood pressure and sympathetic nerve activity after decarboxylase inhibition in cats.
    Watanabe AM, Judy WV, Cardon PV.
    J Pharmacol Exp Ther; 1974 Jan; 188(1):107-13. PubMed ID: 4809262
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological evidence that stimulation of central serotonergic pathways increases renin secretion.
    Zimmermann H, Ganong WF.
    Neuroendocrinology; 1980 Jan; 30(2):101-7, 109. PubMed ID: 6986577
    [Abstract] [Full Text] [Related]

  • 11. L-dopa hypotension in dogs: evidence for mediation through 5-HT release.
    Antonaccio MJ, Robson RD.
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):89-102. PubMed ID: 4281293
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of dopamine in the inhibition of vasopressin secretion by L-dopa in carbidopa-treated dogs.
    Reid IA, Chou L, Chang D, Keil LC.
    Hypertension; 1986 Oct; 8(10):890-6. PubMed ID: 2875946
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of the renal nerves and angiotensin II in the renal function curve.
    Golin R, Genovesi S, Castoldi G, Wijnmaalen P, Protasoni G, Zanchetti A, Stella A.
    Arch Ital Biol; 1999 Aug; 137(4):289-97. PubMed ID: 10443320
    [Abstract] [Full Text] [Related]

  • 20. Effects of L-dopa on myocardial contractile force: a reappraisal.
    Wenger JJ, Osborne MW.
    Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):251-6. PubMed ID: 1190920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.